GONUTS has been updated to MW1.31 Most things seem to be working but be sure to report problems.

Have any questions? Please email us at ecoliwiki@gmail.com

PMID:22028651

From GONUTS
Jump to: navigation, search
Citation

McAdow, M, Kim, HK, Dedent, AC, Hendrickx, AP, Schneewind, O and Missiakas, DM (2011) Preventing Staphylococcus aureus sepsis through the inhibition of its agglutination in blood. PLoS Pathog. 7:e1002307

Abstract

Staphylococcus aureus infection is a frequent cause of sepsis in humans, a disease associated with high mortality and without specific intervention. When suspended in human or animal plasma, staphylococci are known to agglutinate, however the bacterial factors responsible for agglutination and their possible contribution to disease pathogenesis have not yet been revealed. Using a mouse model for S. aureus sepsis, we report here that staphylococcal agglutination in blood was associated with a lethal outcome of this disease. Three secreted products of staphylococci--coagulase (Coa), von Willebrand factor binding protein (vWbp) and clumping factor (ClfA)--were required for agglutination. Coa and vWbp activate prothrombin to cleave fibrinogen, whereas ClfA allowed staphylococci to associate with the resulting fibrin cables. All three virulence genes promoted the formation of thromboembolic lesions in heart tissues. S. aureus agglutination could be disrupted and the lethal outcome of sepsis could be prevented by combining dabigatran-etexilate treatment, which blocked Coa and vWbp activity, with antibodies specific for ClfA. Together these results suggest that the combined administration of direct thrombin inhibitors and ClfA-antibodies that block S. aureus agglutination with fibrin may be useful for the prevention of staphylococcal sepsis in humans.

Links

PubMed PMC3197598 Online version:10.1371/journal.ppat.1002307

Keywords

Agglutination/physiology; Animals; Antibodies, Neutralizing/blood; Antibodies, Neutralizing/immunology; Antithrombins/pharmacology; Bacterial Proteins/metabolism; Carrier Proteins/metabolism; Coagulants/metabolism; Coagulase/immunology; Coagulase/metabolism; Disease Models, Animal; Heart/microbiology; Host-Pathogen Interactions; Humans; Immunization, Passive; Longevity/drug effects; Mice; Mice, Inbred BALB C; Myocardium/pathology; Protein Binding; Sepsis/immunology; Sepsis/microbiology; Sepsis/prevention & control; Staphylococcal Infections/immunology; Staphylococcal Infections/microbiology; Staphylococcus aureus/metabolism; Staphylococcus aureus/pathogenicity; Staphylococcus aureus/ultrastructure; von Willebrand Factor/immunology; von Willebrand Factor/metabolism

Significance

Annotations

Gene product Qualifier GO Term Evidence Code with/from Aspect Extension Notes Status

STAAE:CLFA

involved_in

GO:0009405: pathogenesis

ECO:0000315: mutant phenotype evidence used in manual assertion

P

Seeded From UniProt

complete

STAAE:CLFA

GO:0009405: pathogenesis

ECO:0000315:

P

Fig. 1 Clumping Factor A has shown to be the most important of a three gene system: clfA, vwb, and coa. Mutations to clfA severely impaired agglutination.

complete
CACAO 9596

See also

References

See Help:References for how to manage references in GONUTS.